A. de Boer

639 total citations
22 papers, 501 citations indexed

About

A. de Boer is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. de Boer has authored 22 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Economics and Econometrics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. de Boer's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Meta-analysis and systematic reviews (3 papers) and Statistical Methods in Clinical Trials (3 papers). A. de Boer is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Meta-analysis and systematic reviews (3 papers) and Statistical Methods in Clinical Trials (3 papers). A. de Boer collaborates with scholars based in Netherlands, Canada and United States. A. de Boer's co-authors include Olaf H. Klungel, Arno W. Hoes, K Welvaart, Dirkjan van Schaardenburg, J. Han van Krieken, Jan H. Verheijen, Cornelis F.M. Sier, S Ganesh, K. A. E. Meijers and Johanna M W Hazes and has published in prestigious journals such as PLoS ONE, Journal of Clinical Epidemiology and Annals of Oncology.

In The Last Decade

A. de Boer

20 papers receiving 481 citations

Peers

Countries citing papers authored by A. de Boer

Since Specialization

Citations

This map shows the geographic impact of A. de Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. de Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. de Boer more than expected).

Fields of papers citing papers by A. de Boer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. de Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. de Boer. The network helps show where A. de Boer may publish in the future.

Co-authorship network of co-authors of A. de Boer

This figure shows the co-authorship network connecting the top 25 collaborators of A. de Boer. A scholar is included among the top collaborators of A. de Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. de Boer. A. de Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review 2025 ·Journal of Oncology Pharmacy Practice ·A. de Boer, (unknown), Margaret L. Ackman, (unknown), Anthea Peters, Sheri L. Koshman	0
2	Lost Rate Control and Tachycardia-Induced Cardiomyopathy as a Result of an Interaction Between Enzalutamide and Diltiazem 2025 ·JACC Case Reports ·A. de Boer, Sheri L. Koshman, Gábor Gyenes	0
3	Methodological comparison of marginal structural model, time‐varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture 2016 ·Pharmacoepidemiology and Drug Safety ·M. Sanni Ali, Rolf H. H. Groenwold, Svetlana V. Belitser, Patrick C. Souverein, Elisa Martín‐Merino, Nicolle M. Gatto, Consuelo Huerta, Helga Gardarsdóttir, Kit C. B. Roes, Arno W. Hoes, A. de Boer, Olaf H. Klungel	27
4	The Effect of Eighteen-Month Metformin Treatment in Obese Adolescents: Comparison of Results Obtained in Daily Practice with Results from a Clinical Trial 2016 ·Journal of Obesity ·Marloes P. van der Aa, (unknown), E.M.W. van de Garde, A. de Boer, Catherijne A. J. Knibbe, Marja M. J. van der Vorst	10
5	Prognostic factors of early metastasis and mortality in dogs with appendicular osteosarcoma after receiving surgery: An individual patient data meta-analysis 2013 ·Preventive Veterinary Medicine ·Amand F. Schmidt, M. Nielen, Olaf H. Klungel, Arno W. Hoes, A. de Boer, (unknown), Jolle Kirpensteijn	38
6	Regulatory Scientific Advice on Non-Inferiority Drug Trials 2013 ·PLoS ONE ·Grace Wangge, (unknown), Mirjam J. Knol, Olaf H. Klungel, Christine C. Gispen‐de Wied, A. de Boer, Arno W. Hoes, Hubert G. M. Leufkens, Aukje K. Mantel‐Teeuwisse	18
7	Selection of oncology medicines in low- and middle-income countries 2013 ·Annals of Oncology ·(unknown), A. de Boer, J. H. M. Schellens, H.G.M. Leufkens, Aukje K. Mantel‐Teeuwisse	27
8	Differences in interaction and subgroup-specific effects were observed between randomized and nonrandomized studies in three empirical examples 2013 ·Journal of Clinical Epidemiology ·Amand F. Schmidt, Maroeska M. Rovers, Olaf H. Klungel, Arno W. Hoes, Mirjam J. Knol, M. Nielen, A. de Boer, Rolf H. H. Groenwold	14
9	Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease 2012 ·Resuscitation ·Marieke T. Blom, (unknown), Abdennasser Bardai, Jocelyn Berdowski, Rudolph W. Koster, Patrick C. Souverein, Arno W. Hoes, Frans H. Rutten, A. de Boer, Marie L. De Bruin, Hanno L. Tan	16
10	Risk of venous thromboembolism in patients with total hip/knee replacements and matched controls: A population-based cohort study in Denmark 2012 ·Bone ·(unknown), Peter Vestergaard, S. Pouwels, C. Klop, A. de Boer, Frank de Vries	1
11	Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery 2011 ·Trials ·Grace Wangge, Olaf H. Klungel, Kit CB Roes, A. de Boer, Arno W. Hoes, Mirjam J. Knol	1
12	Interpretation and Inference in Noninferiority Randomized Controlled Trials in Drug Research 2010 ·Clinical Pharmacology & Therapeutics ·Grace Wangge, Olaf H. Klungel, Kit C. B. Roes, A. de Boer, Arno W. Hoes, Mirjam J. Knol	19
13	Effect of drug combinations on admission for recurrent myocardial infarction 2007 ·Heart ·(unknown), Marcel L. Bouvy, C. J. De Blaey, A. de Boer	18
14	Drug Costs Associated with Non-Adherence to Cholesterol Management Guidelines for Primary Prevention of Cardiovascular Disease in an Elderly Population 2006 ·Drugs & Aging ·(unknown), W. M. Monique Verschuren, Aukje K. Mantel‐Teeuwisse, G. Ardine de Wit, Albert Hofman, Paul H. Trienekens, Bruno H. Stricker, A. de Boer, Olaf H. Klungel	10
15	The trade-off between cardiovascular and gastrointestinal effects of rofecoxib 2005 ·Pharmacoepidemiology and Drug Safety ·S. Florentinus, Eibert R. Heerdink, A. de Boer, Liset van Dijk, Hubert G. M. Leufkens	8
16	Horizontal Flow Circulation on a Mixed Energy Beach 2001 ·Aart Kroon, A. de Boer	7
17	A comparison between two types of central venous catheters in the prevention of catheter-related infections: the importance of performing all the relevant cultures 2001 ·Clinical Intensive Care ·Jan van der Vliet, J. A. Leusink, (unknown), A. de Boer	10
18	Ruptured abdominal aortic aneurysms: Factors influencing postoperative mortality and long-term survival 1998 ·European Journal of Vascular and Endovascular Surgery ·(unknown), J. A. Leusink, Frans L. Moll, (unknown), A. de Boer	49
19	Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. 1994 ·PubMed ·S Ganesh, Cornelis F.M. Sier, G Griffioen, H J Vloedgraven, A. de Boer, K Welvaart, (unknown), J. Han van Krieken, Jan H. Verheijen, C. B. H. W. Lamers	136
20	Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis. 1993 ·PubMed ·Dirkjan van Schaardenburg, Johanna M W Hazes, A. de Boer, A. H. Zwinderman, K. A. E. Meijers, FC Breedveld	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Jesky Breakdown of academic impact, for papers by Anthony Fenton Breakdown of academic impact, for papers by Karl Tornyos Breakdown of academic impact, for papers by Choong Won Lee Breakdown of academic impact, for papers by Shouki Bazarbashi Breakdown of academic impact, for papers by Pascal Chaı̈bi Breakdown of academic impact, for papers by Elisabeth Jones Breakdown of academic impact, for papers by Paola Sabrina Buonuomo